Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares traded.
Anthera Pharmaceuticals Trading Down 100.0%
About Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Recommended Stories
- Five stocks we like better than Anthera Pharmaceuticals
- What is a support level?
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- How to trade penny stocks: A step-by-step guide
- The Best Holiday Present You Can Give Yourself? Costco Stock
- Using the MarketBeat Stock Split Calculator
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
